Misonix Stock Forecast for 2023 - 2025 - 2030
Updated on 05/01/2024
Misonix Fair Value Forecast for 2023 - 2025 - 2030
Misonix's Price has grown In the last two years, rising from $0.00 to $0.00 – a growth of 100.00%. In the next year, analysts believe that Fair Value will reach $0.00 – an increase of 100.00%. For the next six years, experts predict that Misonix's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$151.18 | Buy/Sell | $174.55 | 12.45% |
| SYK Stock Forecast | Stryker Corp | Outperform |
10
|
$328.12 | Buy/Sell | $353.16 | 14.44% |
| MDT Stock Forecast | Medtronic | Outperform |
11
|
$80.89 | Buy/Sell | $92.47 | 18.06% |
| MMM Stock Forecast | 3M | Hold |
10
|
$98.44 | Buy/Sell | $109.39 | 3.62% |
| SN. Stock Forecast | Smith & Nephew | Outperform |
18
|
£9.77 | Buy/Sell | £16.09 | 67.04% |
Misonix Revenue Forecast for 2023 - 2025 - 2030
Misonix's Revenue has grown In the last year, rising from $62.48M to $74.02M – a growth of 18.47%. The next year, 0 experts forecast that Misonix's Revenue will decrease by 15.59%, reaching $62.48M. In 2030, professionals predict that Misonix's Revenue will decrease by 9.21%, reaching $67.20M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IART Stock Forecast | Integra LifeSciences Holdings | Hold |
16
|
$29.18 | Buy/Sell | $46.60 | 49.07% |
| MDXG Stock Forecast | MiMedx Group | Buy |
6
|
$7.31 | Buy/Sell | $11.85 | 64.16% |
| UTMD Stock Forecast | Utah Medical Products | - |
18
|
$73.10 | Buy/Sell | $0.00 | -100.00% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| FONR Stock Forecast | FONAR | - |
16
|
$22.17 | Buy/Sell | $0.00 | -100.00% |
| CUTR Stock Forecast | Cutera | Outperform |
6
|
$2.45 | Buy/Sell | $7.67 | 144.90% |
| APYX Stock Forecast | Apyx Medical | Outperform |
7
|
$1.40 | Buy/Sell | $4.67 | 60.71% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IRIX Stock Forecast | IRIDEX | Hold |
9
|
$2.82 | Buy/Sell | $2.00 | -29.08% |
| AVGR Stock Forecast | Avinger | Outperform |
9
|
$3.68 | Buy/Sell | $5.00 | 35.87% |
| NURO Stock Forecast | NeuroMetrix | - |
-7
|
$3.00 | Buy/Sell | $50.00 | -100.00% |
Misonix EBITDA Forecast for 2023 - 2025 - 2030
In the last year, Misonix's EBITDA has fallen from $-12.77M to $-4.66M – a 63.51% decrease. In the next year, analysts predict that EBITDA will jump to $-12.77M – up 174.03% from the current level. Looking ahead to nine years, experts forecast that EBITDA will grow by 214.57%.
Misonix EBIT Forecast for 2023 - 2025 - 2030
Misonix's EBIT has decreased In the last year, from $-16.29M to $-9.24M – a 43.28% drop. Analysts predict that Misonix's EBIT will increase in the upcoming year, reaching $-16.29M. This would represent an increase of 76.30%. Over the next nine years, experts predict that Misonix's EBIT will grow at a rate of 68.99%.
Misonix EPS Price Prediction Forecast for 2023 - 2025 - 2030
Misonix's EPS has grown In the last two years, rising from $0.00 to $0.00 – a growth of 100.00%. In the next year, analysts believe that EPS will reach $0.00 – an increase of 100.00%. For the next six years, experts predict that Misonix's EPS will grow at a rate of 100.00%.
.jpg)